August 15, 2026 02:32 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Ajit Doval breaks silence on Operation Sindoor in Discovery’s explosive new docuseries | Rahul Gandhi's 'mock hug' taunt sparks row; Centre stresses 'mutual respect' with Italy | Delhi on high alert: Bomb threat to High Court, airport and multiple locations ahead of I-Day | ‘Who are they to interfere?’: CJI Surya Kant slams Bar Council of India over NALSAR students’ enrolment row | 'Shows how low Congress has sunk': BJP slams Rahul Gandhi over Modi foreign policy jibe | From guns to glamour: Former women Maoists walk the ramp in Chhattisgarh | Netaji row: Suvendu Adhikari govt strips BJP MP Anant Maharaj of state honour | Sukhbir Badal attacked by Nihang Sikh with kirpan at Maharashtra gurdwara; assailant detained | ‘If you cannot do it, we will pass an order’: Supreme Court’s final warning to Centre on food labels | ‘Time to move on’: Bombay HC sends strong message in Vijay Mallya-bank dispute
Imran Khan

Pakistani Prime Minister Imran Khan oks COVID-19 vaccine procurement from 2 firms - Reports

| @indiablooms | Nov 17, 2020, at 11:10 pm

Moscow/Sputnik: Pakistani Prime Minister Imran Khan has greenlighted advance booking of COVID-19 vaccines with two unnamed candidates in the running, media reported Tuesday.

According to news outlet Geo Pakistan, Parliamentary Secretary for Health Nausheen Hamid said that 10 million Pakistani nationals will be vaccinated during the first phase, with the priority given to frontline workers and people aged over 65 years.

No details of the origin of the shortlisted vaccines were given, although Pakistan’s coronavirus taskforce last week indicated that authorities will consider Chinese-made vaccines over US-made ones due to the different requirements in transportation and storage, Geo Pakistan reported.

The vaccines produced by US firms Pfizer and Moderna must be stored in temperatures of -30 to -90 degrees Fahrenheit, requiring what is called a cold chain, a major challenge for vaccine distribution in developing nations.

Chinese-made vaccines, which are currently undergoing third phase trials in Pakistan, remain effective at room temperatures, Geo reported citing the taskforce.

Fewer than a dozen vaccine candidates are showing efficacy in the third phase trials, mainly from the US, Russia and China, while many other COVID-19 vaccine developments are still underway. Many nations have begun scrambling to secure pledges of vaccine procurement before they are mass-produced.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.